Vice president of Google Health and former chairman and CEO of Johnson & Johnson to discuss ‘Innovations in Health Care and Health Technology Post-COVID-19’

July 08, 2020

The Way Forward logo

Dr. David Feinberg, vice president of Google Health, and William Weldon, former chairman and CEO of Johnson & Johnson, will discuss “Innovations in Health Care and Health Technology Post-COVID-19” with Quinnipiac University President Judy Olian and Dr. Bruce Koeppen, dean of the Frank H. Netter MD School of Medicine, at 11 a.m. on Thursday, July 9. This virtual event, which is free and open to the public, is part of “The Way Forward: The Quinnipiac President’s Speaker Series.”

Feinberg and Weldon will discuss the pandemic’s impact on the delivery of health care, including innovations in at-home diagnostic equipment, how Google Health is studying the use of artificial intelligence to assist with clinical diagnoses and patient outcomes, and trends in data privacy and digital health.

“I am grateful to have these two national health care leaders meet with our Quinnipiac community and am looking forward to an informative discussion about how technology can enhance care delivery and the interactions of physicians with their patients,” Dr. Koeppen said.

Feinberg currently leads Google Health, a team employing Google's expertise in AI, product innovation, and hardware to take on big health care challenges. Previously, Feinberg was president and CEO of Geisinger, one of the nation’s most innovative health services organizations. While at Geisinger, he oversaw 13 hospital campuses, a 600,000-member health plan, research centers, and various initiatives aimed at better engaging patients around their health and wellbeing. Prior to Geisinger, Feinberg served as CEO of UCLA’s hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of the UCLA Health System.

After graduating from Quinnipiac in 1971, Weldon began his lifelong career with Johnson & Johnson, where he was hired as an entry-level sales representative. He rapidly rose through the ranks of the company, serving in several sales, marketing and international management positions before becoming president of Ethicon Endo-Surgery at Johnson & Johnson in 1992 and later company group chairman in 1994. He was appointed to the executive committee as worldwide chairman of the Pharmaceuticals Group in 1998 before being named chairman and CEO of Johnson & Johnson in 2002. In the company's then 116-year history, only five individuals had held that role. During his successful tenure, Weldon strategically led Johnson & Johnson through the 2008 recession, ensuring the company was well-positioned for future growth when he retired in 2012. Weldon is currently a member of the board of trustees at Quinnipiac.

The Way Forward speaker series features thoughtful conversations about today’s social, economic and health challenges, and the trailblazing ideas that will drive solutions for tomorrow.

Stay in the Loop

Sign Up Now